AXIM BIOTECHNOLOGIES, INC. (15)
Browse by Contract Category
Contracts
-
Binding Term Sheet Agreement dated August 3, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC
(Filed With SEC on April 15, 2022)
-
Description of Securities
(Filed With SEC on April 15, 2022)
-
Termination Agreement dated March 3, 2022, by and between AXIM Biotechnologies, Inc. and Empowered Diagnostics, LLC
(Filed With SEC on April 15, 2022)
-
Asset Purchase Agreement dated August 26, 2021, by and between AXIM Biotechnologies, Inc. and Advanced Tear Diagnostics, LLC
(Filed With SEC on April 15, 2022)
-
PROMISSORY NOTE
(Filed With SEC on February 16, 2022)
-
CONVERTIBLE NOTE
(Filed With SEC on February 16, 2022)
-
AXIM BIOTECHNOLOGIES, INC. 6% CONVERTIBLE REDEEMABLE NOTE DUE SEPTEMBER 29, 2022
(Filed With SEC on February 16, 2022)
-
EQUITY PURCHASE AGREEMENT
(Filed With SEC on May 14, 2021)
-
EQUITY PURCHASE AGREEMENT
(Filed With SEC on May 14, 2021)
-
(Filed With SEC on May 14, 2020)
-
(Filed With SEC on March 19, 2020)
-
(Filed With SEC on March 19, 2020)
-
(Filed With SEC on January 8, 2020)
-
AMENDMENT NO. 1 TO STOCK PURCHASE AGREEMENT
(Filed With SEC on December 17, 2019)
-
PREFERRED STOCK PURCHASE AGREEMENT
(Filed With SEC on February 26, 2019)